Krystal Biotech awarded director Sutherland Everett Rand 1,658 derivative securities in two transactions dated 2026-09-14, each priced at $0 per share. The code A classification identifies the entries as awards or grants, helping investors distinguish the reported transaction from an open-market purchase.
Key Highlights
- The award was divided across two separate transactions.
- Each transaction carried a price of $0 per share.
- Transaction code A identifies the entries as awards or grants.
Krystal Biotech, Inc. (NASDAQ: KRYS) awarded director Sutherland Everett Rand 1,658 derivative securities across two transactions, with both entries dated 14 September 2026. Each transaction was priced at $0 per share. The records use transaction code A.
Director Award Covers 1,658 Derivative Securities
Rand’s award was recorded through two separate transactions rather than a single entry, while the combined number of derivative securities was 1,658. The transaction date attached to both entries was 14 September 2026, keeping the award within one reported date. The price assigned to each transaction was $0 per share. That amount applies to the derivative securities covered by the entries and does not represent a separate figure for the overall award. Transaction code A identifies an award or grant under the transaction coding convention used for these records. The code therefore describes the nature of both entries as awards or grants. Rand is identified as a director of Krystal Biotech, Inc. and the securities involved are derivative securities of the company. Transaction code A denotes an award, grant, or other Acquisition from the company.
FAQs
Q: How many derivative securities did Krystal Biotech award Sutherland Everett Rand?
A: Krystal Biotech awarded director Sutherland Everett Rand 1,658 derivative securities. The award was divided across two separate transactions.
Q: What price was listed for Sutherland Everett Rand’s KRYS transactions?
A: Each transaction involving Sutherland Everett Rand’s derivative securities was listed at $0 per share. Both entries were dated 14 September 2026.
Q: What does transaction code A mean in the Krystal Biotech record?
A: Transaction code A identifies an award or grant. Both of Rand’s transactions used that classification for the derivative securities.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.